Accès ouvert
2026
article
OpenAlex
Huixin Chen, Rong Luo, Jiakang Ma, Weiheng Cui et autres
Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, limiting the applicability of endocrine and HER2-targeted therapies. Clinically, TNBC exhibits marked molecular heterogeneity, aggressive behavior, early …
cn, gr
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Zhimeng Yao, Yuhua Meng, Huanyi Li, Yinhui Jiang et autres
Cancer therapy-related cognitive impairment (CTRCI) is a debilitating neurotoxic condition adversely impacting cancer patients during and post-cancer treatments. The cancer treatments linked to CTRCI include chemotherapy, hormone therapy, targeted therapy, and immunotherapy. Despite CTRCI severely affecting the psychological and social, cognitive functions, …
cn, us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Yunlong Pan, Haolin Wu, Qingyun Guo, Xingyue Fang et autres
Ranked as the most prevalent cause of death worldwide, ischemic stroke urgently requires innovative therapeutic strategies. The present study demonstrates the therapeutic potential of human umbilical cord-derived mesenchymal stem cell-derived exosomes (hUMSC-Exos) in ameliorating hypoxia-induced cerebrovascular endothelial dysfunction through modulation of the …
cn, kr
(code pays fourni par la source)
2025
article
OpenAlex
Jiashuai He, Yiran Zhang, Simin Luo, Zhan Zhao et autres
cn
(code pays fourni par la source)
2025
article
OpenAlex
Yunlong Pan, Xiaohong Zhang, Xifeng Zhang, Weihua Zhu et autres
cn, Afrique du Sud
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Zhan Zhao, Jiashuai He, Shenghui Qiu, Lu Wang et autres
Metastatic BRAFV600E colorectal cancer (CRC) confers poor prognosis and represents a therapeutic bottleneck. To identify resistance mechanisms of the mitogen-activated protein kinase (MAPK) pathway in BRAFV600E CRC, we perform genome-wide CRISPR-Cas9 screening and discover that targeting glutathione peroxidase 4 (GPX4) overcomes resistance …
cn, th
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Yu Chen, Minyu Jiang, Shibin Zhu, Yunlong Pan et autres
Accès ouvert
2024
article
OpenAlex
Hongbo Su, Shuping Xie, Shanshan Wang, Liying Huang et autres
Purpose: Competing-risk analysis was used to accurately assess prognostic factors for cancer-specific death in patients with adenocarcinoma of transverse colon (ATC), and the results were compared with those from a conventional Cox regression analysis. Materials and Methods: Patients diagnosed with ATC between …
cn
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Yangzhi Hu, Zhili Hu, Tianyou Liao, Yuan Li et autres
The transformation of tumor cells from an epithelial to a mesenchymal-like phenotype, designated as epithelial-to-mesenchymal transition (EMT), represents a key hallmark of human cancer metastasis, including gastric cancer (GC). However, a large set of non-coding RNAs have been studied for their functions …
cn
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Jianlin Zhu, Lu Wang, Fan Liu, Jinghua Pan et autres
Abnormal angiogenesis is one of the important hallmarks of colorectal cancer as well as other solid tumors. Optimally, anti-angiogenesis therapy could restrain malignant angiogenesis to control tumor expansion. PELP1 is as a scaffolding oncogenic protein in a variety of cancer types, but …
cn, nl
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Jiashuai He, Shijin Liu, Yiran Zhang, Xiaodong Chu et autres
Immunotherapy of malignant tumor is a verified and crucial anti-tumor strategy to help patients with cancer for prolonging prognostic survival. It is a novel anticancer tactics that activates the immune system to discern and damage cancer cells, thereby prevent them from proliferating. …
cn
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Yangzhi Hu, Zhili Hu, Hui Ding, Yuan Li et autres
Background: We aimed to identify the key differentially expressed genes (DEGs) associated with poor prognosis in gastric cancer (GC) and to elucidate the underlying molecular mechanisms in order to provide a therapeutic target for this disease. Methods: The DEGs common in two …
cn
(code pays fourni par la source)